- Home
- MGPI vs CTMX Comparison
MGPI vs CTMX Comparison
Compare MGPI & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- CTMX
- Stock Information
- Founded
- MGPI 1941
- CTMX 2008
- Country
- MGPI United States
- CTMX United States
- Employees
- MGPI N/A
- CTMX N/A
- Industry
- MGPI Beverages (Production/Distribution)
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- CTMX Health Care
- Exchange
- MGPI Nasdaq
- CTMX Nasdaq
- Market Cap
- MGPI 610.9M
- CTMX 596.2M
- IPO Year
- MGPI 1988
- CTMX 2015
- Fundamental
- Price
- MGPI $24.30
- CTMX $3.26
- Analyst Decision
- MGPI Strong Buy
- CTMX Strong Buy
- Analyst Count
- MGPI 5
- CTMX 5
- Target Price
- MGPI $44.60
- CTMX $5.80
- AVG Volume (30 Days)
- MGPI 208.9K
- CTMX 3.4M
- Earning Date
- MGPI 10-29-2025
- CTMX 11-07-2025
- Dividend Yield
- MGPI 1.97%
- CTMX N/A
- EPS Growth
- MGPI N/A
- CTMX 263.20
- EPS
- MGPI N/A
- CTMX 0.49
- Revenue
- MGPI $609,404,000.00
- CTMX $141,100,000.00
- Revenue This Year
- MGPI N/A
- CTMX N/A
- Revenue Next Year
- MGPI N/A
- CTMX N/A
- P/E Ratio
- MGPI N/A
- CTMX $6.67
- Revenue Growth
- MGPI N/A
- CTMX 18.01
- 52 Week Low
- MGPI $23.28
- CTMX $0.40
- 52 Week High
- MGPI $59.65
- CTMX $3.91
- Technical
- Relative Strength Index (RSI)
- MGPI 38.88
- CTMX 54.42
- Support Level
- MGPI $23.28
- CTMX $3.21
- Resistance Level
- MGPI $25.33
- CTMX $3.91
- Average True Range (ATR)
- MGPI 0.61
- CTMX 0.26
- MACD
- MGPI 0.20
- CTMX -0.05
- Stochastic Oscillator
- MGPI 45.64
- CTMX 22.94
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.